GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $165,000 | -89.5% | 62,350 | -73.7% | 0.00% | -100.0% |
| Q2 2020 | $1,574,000 | -61.5% | 237,068 | -66.3% | 0.00% | -33.3% |
| Q1 2020 | $4,092,000 | +24.2% | 703,226 | +91.4% | 0.00% | -25.0% |
| Q4 2019 | $3,295,000 | -1.6% | 367,332 | -5.3% | 0.00% | 0.0% |
| Q3 2019 | $3,348,000 | +2.6% | 387,692 | +32.3% | 0.00% | -42.9% |
| Q2 2019 | $3,264,000 | -9.4% | 293,030 | +8.2% | 0.01% | -12.5% |
| Q1 2019 | $3,602,000 | +214.3% | 270,840 | +265.1% | 0.01% | +166.7% |
| Q4 2018 | $1,146,000 | -19.5% | 74,190 | -25.8% | 0.00% | 0.0% |
| Q3 2018 | $1,424,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
| Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
| Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
| Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
| ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
| SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
| Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
| CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
| XTX Topco Ltd | 50,517 | $130,000 | 0.03% |